Back to search

Article

Identification of hypoxia- and immune- based prognostic signature and validation of TFRC as a potential biomarker and therapeutic target in bladder cancer

2023-12-13

Abstract excerpt

<h4>Background: </h4> Bladder cancer is a common malignancy of the urinary system, and the survival rate and recurrence rate of patients with muscular aggressive (MIBC) bladder cancer are not ideal. Hypoxia is a pathological process in which cells acquire special characteristics to adapt to anoxic environment, which can directly affect the proliferation, invasion and immune response of bladder cancer cells. Unders...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
d2403578-d12f-51d6-9637-bddd03849d67
DOI
10.21203/rs.3.rs-3718584/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Identification of hypoxia- and immune- based prognostic signature and validation of TFRC as a potential biomarker and therapeutic target in bladder cancerDOI 10.21203/rs.3.rs-3718584/v1
Identification of hypoxia- and immune- based prognostic signature and validation of TFRC as a potential biomarker and therapeutic target in BLCASemantic proximity
TFRC, associated with hypoxia and immune, is a prognostic factor and potential therapeutic target for bladder cancerSemantic proximity
Identification and Validation of A Hypoxia-Related Prognostic and Immune Microenvironment Signature in Bladder CancerSemantic proximity
Identification and validation of a hypoxia-related prognostic and immune microenvironment signature in bladder cancerSemantic proximity
Hypoxia score for predicting prognosis and tumor response to immunotherapy in bladder urothelial carcinomaSemantic proximity
Integrative analysis of immune molecular subtypes and microenvironment characteristics of bladder cancer.Semantic proximity
New exploration of bladder cancer-related immune gene biomarkers in predicting the prognosis of urinary system tumorsSemantic proximity
Immune and Stromal Signature-Based Prognostic Gene of Bladder CancerSemantic proximity
Development and validation of a glycolysis-associated gene signature for predicting the prognosis, immune landscape, and drug sensitivity in bladder cancerSemantic proximity
Development of A Prognostic Index and Screening of Prognosis Related Genes Based on an Immunogenomic Landscape Analysis of Bladder CancerSemantic proximity
Risk stratification based on immune signature and prediction of immune checkpoint inhibitor’s efficacy for bladder urothelial carcinomaSemantic proximity
An Immune-Related lncRNA Model for Predicting Prognosis, Immune Landscape and Chemotherapeutic Response in Bladder CancerSemantic proximity
Select a neighboring publication to make it the new centre.